Cargando…

Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway

Resibufogenin (RBF), an active compound from Bufo bufonis, has been used for the treatment of multiple malignant cancers, including pancreatic cancer, colorectal cancer, and breast cancer. However, whether RBF could exert its antitumor effect by inhibiting angiogenesis remains unknown. Here, we aime...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ting, Jiang, Yi-Xin, Wu, Ye, Lu, Dong, Huang, Rui, Wang, Long-Ling, Wang, Shi-Qi, Guan, Ying-Yun, Zhang, Hong, Luan, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121540/ https://www.ncbi.nlm.nih.gov/pubmed/33995111 http://dx.doi.org/10.3389/fphar.2021.682735

Ejemplares similares

Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway
por: Li, Jia, et al.
Publicado: (2019)

Saikosaponin A, a Triterpene Saponin, Suppresses Angiogenesis and Tumor Growth by Blocking VEGFR2-Mediated Signaling Pathway
por: Zhang, Pan, et al.
Publicado: (2021)

Resibufogenin Targets the ATP1A1 Signaling Cascade to Induce G2/M Phase Arrest and Inhibit Invasion in Glioma
por: Zhang, Xun, et al.
Publicado: (2022)

Resibufogenin suppresses colorectal cancer growth and metastasis through RIP3-mediated necroptosis
por: Han, Qinrui, et al.
Publicado: (2018)

FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer
por: Shiau, Jun-Ping, et al.
Publicado: (2021)

Resibufogenin and Cinobufagin Activate Central Neurons through an Ouabain-Like Action
por: Wang, Ze-Jun, et al.
Publicado: (2014)

M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2
por: Dong, Fang, et al.
Publicado: (2020)

Coix Seed Oil Exerts an Anti–Triple-Negative Breast Cancer Effect by Disrupting miR-205/S1PR1 Axis
por: Fang, Ting, et al.
Publicado: (2020)

Jujuboside B suppresses angiogenesis and tumor growth via blocking VEGFR2 signaling pathway
por: Zhang, Pan, et al.
Publicado: (2023)

Resibufogenin inhibits the malignant characteristics of multiple myeloma cells by blocking the PI3K/Akt signaling pathway
por: Zhou, Yan, et al.
Publicado: (2022)

Correction: M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2
por: Dong, Fang, et al.
Publicado: (2022)

Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway
por: Zhu, Yingjun, et al.
Publicado: (2020)

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)

The Emerging Regulation of VEGFR-2 in Triple-Negative Breast Cancer
por: Zhu, Xiaoxia, et al.
Publicado: (2015)

DSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis
por: Choi, Hyeong Sim, et al.
Publicado: (2016)

SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2
por: Choi, Hyeong Sim, et al.
Publicado: (2016)

Sialyllactose suppresses angiogenesis by inhibiting VEGFR-2 activation, and tumor progression
por: Chung, Tae-Wook, et al.
Publicado: (2017)

Crocetin and Its Glycoside Crocin, Two Bioactive Constituents From Crocus sativus L. (Saffron), Differentially Inhibit Angiogenesis by Inhibiting Endothelial Cytoskeleton Organization and Cell Migration Through VEGFR2/SRC/FAK and VEGFR2/MEK/ERK Signaling Pathways
por: Zhao, Chen, et al.
Publicado: (2021)

Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1–TAZ Signaling Pathway
por: Kong, Lu, et al.
Publicado: (2022)

Oestrogen Inhibits VEGF Expression And Angiogenesis In Triple-Negative Breast Cancer By Activating GPER-1
por: Wang, Chen, et al.
Publicado: (2018)

BET Bromodomain Suppression Inhibits VEGF-induced Angiogenesis and Vascular Permeability by Blocking VEGFR2-mediated Activation of PAK1 and eNOS
por: Huang, Mingcheng, et al.
Publicado: (2016)

Eupalinolide J Suppresses the Growth of Triple-Negative Breast Cancer Cells via Targeting STAT3 Signaling Pathway
por: Lou, Chenghua, et al.
Publicado: (2019)

AAV-CRISPR/Cas9–Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro
por: Wu, Wenyi, et al.
Publicado: (2017)

Sanguisorba officinalis L. Suppresses Triple-Negative Breast Cancer Metastasis by Inhibiting Late-Phase Autophagy via Hif-1α/Caveolin-1 Signaling
por: Wang, Neng, et al.
Publicado: (2020)

Blockade of VEGFR1 and 2 Suppresses Pathological Angiogenesis and Vascular Leakage in the Eye
por: Huang, Hu, et al.
Publicado: (2011)

Gallic acid suppresses the progression of triple-negative breast cancer HCC1806 cells via modulating PI3K/AKT/EGFR and MAPK signaling pathways
por: Lin, Si, et al.
Publicado: (2022)

Isoliquiritigenin Derivative Regulates miR-374a/BAX Axis to Suppress Triple-Negative Breast Cancer Tumorigenesis and Development
por: Peng, Fu, et al.
Publicado: (2020)

Corrigendum: Sanguisorba officinalis L. Suppresses Triple-Negative Breast Cancer Metastasis by Inhibiting Late-Phase Autophagy via Hif-1α/Caveolin-1 Signaling
por: Wang, Neng, et al.
Publicado: (2022)

The Clinical Value of Chemotherapy Combined With Capecitabine in Triple-Negative Breast Cancer—A Meta-Analysis
por: Zhang, Zilin, et al.
Publicado: (2021)

Enhancement of Dissolving Capacity and Reducing Gastric Mucosa Irritation by Complex Formation of Resibufogenin with β-Cyclodextrin or 2-Hydroxypropyl-β-cyclodextrin
por: Liu, Nan, et al.
Publicado: (2022)

Predictive value of PD-L1 expression to the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer: A systematic review and meta-analysis
por: Qi, Yingjie, et al.
Publicado: (2022)

Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy
por: Chu, Qiuchen, et al.
Publicado: (2016)

α-Mangostin Alleviated HIF-1α-Mediated Angiogenesis in Rats With Adjuvant-Induced Arthritis by Suppressing Aerobic Glycolysis
por: Jiang, Tian-Tian, et al.
Publicado: (2021)

Extract of Marsdenia tenacissima (Roxb.) Moon [Apocynaceae] Suppresses Hepatocellular Carcinoma by Inhibiting Angiogenesis
por: Pan, Yating, et al.
Publicado: (2022)

Editorial: Apoptosis Induction/Suppression: A Feasible Approach for Natural Products to Treatment of Diseases, Volume II
por: Peng, Wei, et al.
Publicado: (2022)

SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer
por: Liu, Peng, et al.
Publicado: (2018)

Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma
por: Yuan, Xiao-Han, et al.
Publicado: (2018)

Sinensetin suppresses angiogenesis in liver cancer by targeting the VEGF/VEGFR2/AKT signaling pathway
por: Li, Xiao, et al.
Publicado: (2022)

Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma
por: Song, Fei, et al.
Publicado: (2020)

Cinnamon extract inhibits angiogenesis in zebrafish and human endothelial cells by suppressing VEGFR1, VEGFR2, and PKC-mediated MAP kinase
por: Bansode, Rishipal R, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lhlrh11nbbg7n97bvbml646vqr